BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11074595)

  • 1. Role of the phosphorolysis of deoxyadenosine in the cytotoxic effect of the combination of deoxyadenosine and deoxycoformycin on a human colon carcinoma cell line (LoVo).
    Giorgelli F; Giannecchini M; Bemi V; Turchi G; Sgarrella F; Tozzi MG; Camici M
    J Cell Biochem; 2000 Oct; 80(2):241-7. PubMed ID: 11074595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyadenosine metabolism in a human colon-carcinoma cell line (LoVo) in relation to its cytotoxic effect in combination with deoxycoformycin.
    Bemi V; Tazzni N; Banditelli S; Giorgelli F; Pesi R; Turchi G; Mattana A; Sgarrella F; Tozzi MG; Camici M
    Int J Cancer; 1998 Mar; 75(5):713-20. PubMed ID: 9495239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-Deoxyadenosine causes apoptotic cell death in a human colon carcinoma cell line.
    Giannecchini M; D'Innocenzo B; Pesi R; Sgarrella F; Iorio M; Collecchi P; Tozzi MG; Camici M
    J Biochem Mol Toxicol; 2003; 17(6):329-37. PubMed ID: 14708088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the inhibition of repair of irradiation-induced DNA damage by 2'-deoxycoformycin and deoxyadenosine.
    Begleiter A; Verburg L; Israels LG; Johnston JB
    Cancer Chemother Pharmacol; 1992; 30(1):65-9. PubMed ID: 1586982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycoplasma contamination alters 2'-deoxyadenosine metabolism in deoxycoformycin-treated mouse leukemia cells.
    Plagemann PG; Woffendin C
    J Cell Biochem; 1990 Jun; 43(2):161-72. PubMed ID: 2380261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine enzyme profile in human colon-carcinoma cell lines and differential sensitivity to deoxycoformycin and 2'-deoxyadenosine in combination.
    Camici M; Turriani M; Tozzi MG; Turchi G; Cos J; Alemany C; Miralles A; Noe V; Ciudad CJ
    Int J Cancer; 1995 Jul; 62(2):176-83. PubMed ID: 7622293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
    Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
    Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of adenosine deaminase inhibition and deoxyadenosine induces apoptosis in a human astrocytoma cell line.
    Garcia-Gil M; Tozzi MG; Varani S; Della Verde L; Petrotto E; Balestri F; Colombaioni L; Camici M
    Neurochem Int; 2015 Jan; 80():14-22. PubMed ID: 25447764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
    Begleiter A; Pugh L; Israels LG; Johnston JB
    Cancer Res; 1988 Jul; 48(14):3981-6. PubMed ID: 3260129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS; Hershfield MS
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS; Yu J; Yu AL
    J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
    Kang GJ; Kimball AP
    Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells.
    Kodama EN; McCaffrey RP; Yusa K; Mitsuya H
    Biochem Pharmacol; 2000 Feb; 59(3):273-81. PubMed ID: 10609556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin.
    Johnston JB; Lee K; Verburg L; Blondal J; Mowat MR; Israels LG; Begleiter A
    Leuk Res; 1992 Aug; 16(8):781-8. PubMed ID: 1528066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
    Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
    J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M; Kimura K
    Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair in nondividing human lymphocytes: inhibition by deoxyadenosine.
    Cohen A; Thompson E
    Cancer Res; 1986 Apr; 46(4 Pt 1):1585-8. PubMed ID: 3485013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cordycepin (3'-deoxyadenosine) pentostatin (deoxycoformycin) combination treatment of mice experimentally infected with Trypanosoma evansi.
    Dalla Rosa L; da Silva AS; Gressler LT; Oliveira CB; Dambrós MG; Miletti LC; França RT; Lopes ST; Samara YN; da Veiga ML; Monteiro SG
    Parasitology; 2013 Apr; 140(5):663-71. PubMed ID: 23361035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
    Niitsu N; Umeda M; Honma Y
    Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin.
    Brox L; Ng A; Pollock E; Belch A
    Cancer Res; 1984 Mar; 44(3):934-7. PubMed ID: 6607110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.